Find a Provider

Mark A. Morgan, MD

Mark A. Morgan, MD Physician

Chief, Gynecology Oncology
Director, Gynecology Oncology at Pennsylvania Hospital
John J. Mikuta, M.D. Professor of Gynecologic Oncology in the Department of Obstetrics and Gynecology

Dr. Morgan is a Penn Medicine employed physician.

About Dr. M Morgan

Recognized annually in Philadelphia Magazine's Top Doc Issue from 1994 through 2015

Recognized by America's Top Doctors 2008-2014

Recognized by Best Doctors in America 2007-2012, 2013-2014

Clinical Specialties

Specialties:

  • Obstetrics & Gynecology

Programs & Services:

  • Cancer
    • Jordan Center for Gynecologic Cancers
    • Merkel Cell Carcinoma
  • Obstetrics and Gynecology
    • Gynecologic oncology

Board Certification:

  • Obstetrics and Gynecology - Gynecologic Oncology, 1992
  • Obstetrics and Gynecology, 1989

Conditions & Treatments:

  • abnormal pap smear
  • Cervical Cancer
  • cervical cerclage
  • cervical lesions
  • cervix biopsy
  • Endometrial Cancer
  • gynecologic cancer surgery
  • gynecologic surgery
  • gynecology clinical trials
  • hysterectomy
  • hysterectomy - minimally invasive
  • hysteroscopic surgery
  • laparoscopic hysterectomy
  • laparoscopy
  • LEEP procedure
  • Ovarian Cancer
  • rectovaginal fistula
  • supracervical hysterectomy - laparoscopic
  • Uterine Cancer
  • uterine myoma
  • Vaginal Cancer
  • vaginal hysterectomy
  • vesicovaginal fistula
  • Vulvar Cancer

Clinical Interests

Gynecologic Oncology; Urogynecology

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Care
  • Rail Road Medicare / Palmetto GBA
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: State University of New York at Brooklyn
Residency: Hospital of the University of Pennsylvania
Fellowship: Hospital of the University of Pennsylvania

Memberships

American College of Obstetricians and Gynecologists, National American College of Surgeons, National American Society for Colposcopy and Cervical Pathology, National American Society of Clinical Oncology, National American Urogynecologic Society, National College of Physicians of Philadelphia, Local Gynecologic Oncology Group, National International Gynecologic Cancer Society, International National Comprehensive Cancer Network, National Philadelphia Obstetrical Society, Local Society of Gynecologic Oncologists, National Society of Pelvic Surgeons, National World Health Organization, International

Affiliation

Dr. Morgan is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.

Research

Research Interests:

Clinical trials

Selected Publications:

Farley J, Brady WE, Vathipadiekal V, Lankes HA, Coleman R, Morgan MA, Mannel R, Yamada SD, Mutch D, Rodgers WH, Birrer M, Gershenson DM: Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or perineum: an open label, single-arm, phase 2 study. The Lancet 4(2):134-140 : 2013.

Myers SB, Manne SL, Kissane DW, Ozga M, Kashy DA, Rubin S, Heckman C, Rosenblum N, Morgan M, Graff JJ: Social-cognitive processes associated with fear of recurrence among women newly diagnosed with gynecologic cancers. Gynecol Oncol 128(1):120-127 : 2013.

Chu CS, Boyer J, Schullery DS, Gimotty PA, Gamerman V, Bender J, Levine BL, Coukos G, Rubin SC, Morgan MA, Vonderheide RH, June CH: Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission. Cancer Immunol Immunother 61(5):629-641. : 2012.

Morgan MA, Sill MW, Fujiwara K, Greer B, Rubin SC, DeGeest K, Yamada SD, Waggoner S, Coleman, RL, Walker JL, Mannel RS: A Phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in unreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study. Gynecol Oncol 121(2):264-68 : 2011.

Partridge EE, Abu-Rustum NR, Campos SM, Fahey PJ, Farmer M, Garcia RL, Giuliano A, Jones HW, Lele SM, Lieberman RW, Massad SL, Morgan MA, Reynolds RK, Rhodes HE, Singh DK, Smith-McCune K, Teng N, Trimble CL, Valea F, Wilczynski S: Cervical Cancer Screening. J Nat’l Compr Canc Netw 8(12):1358-86 : 2010.

Greer BE, Koh WJ, Abu-Rustum NR, Apte SM, Campos SM, Chan J, Cho KR, Copeland L, Crispens MA, DuPont N, Eifel PJ, Gaffney DK, Huh WK, Kapp DS, Lurain JR, Martin L, Morgan MA, Morgan RJ, Mutch D, Remmenga SW, Reynolds RK, Small W, Teng N, Valea FA: Cervical Cancer. J Nat’l Compr Canc Netw 8(12):1388-416 : 2010.

Morgan MA, Polan ML, Melecot HH, Debru B, Sleemi A, Husain A: Experience with a low-pressure colonic pouch (Mainz II) urinary diversion for irreparable vesicovaginal fistula and bladder extrophy in East Africa. Int Urogynecol J 20:1163-1168 : 2009.

Greer BE, Koh WJ, Abu-Rustum N, Bookman, MA, Bristow RE, Campos SM, Cho, KR, Copeland L, Crispens MA, Eifel PJ, Huh WK, Jagernauth W, Kapp DS, Kavanagh JJ, Lurain JR 3rd, Morgan MA, Morgan RJ, Powell CB, Remmenga SW, Reynolds RK, Alvarez Secord A, Small W Jr., Teng N.: NCCN Clinical Practice Guidelines in Oncology: Uterine Neoplasms. J Natl Compr Canc Netw 7(5):498-531 : 2009.

Novi JM, Mulvihill BHK, Morgan MA: Combined Anal Sphincteroplasty and Perineal Reconstruction for Fecal Incontinence in Women. JAOA 109(4):234-236 : 2009.

Kavanagh JJ, Sill MW, Ramirez PT, Warshal D, Pearl ML, Morgan MA: Phase II multicenter open-label study of karenitecin in previously treated epithelial ovarian and primary peritoneal cancer: A Gynecologic Oncology Group Study. Int J Gynecol Cancer 18(3):460-464 : 2008.

Academic Contact Info

Jordan Center for Gynecologic Oncology at Penn Perelman Center for Advanced Medicine
3400 Civic Center Blvd.
3rd Floor West

Philadelphia, PA 19104
Phone: (215) 662-3318
Fax: (215) 349-5849
Patient appointments: 800-789-PENN (7366)